Chunbo Dong - Concepedia

Author

Chunbo Dong

The University of Texas Southwestern Medical Center ORCID

Also Known As

Chunbo Dong

Publications

783

Citations

H-Index

Concepts

All Affiliations

The University of Texas Southwestern Medical Center Shanxi Academy of Building Research Southwestern Medical Center Tsinghua University

About

Chunbo Dong is an author at The University of Texas Southwestern Medical Center specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	448
2	Immunology	5	5	448
3	Cell Biology	4	4	355
4	Engineering	1	1	114
5	Cancer Therapeutics	1	1	61

Chunbo Dong

Publications

768

Citations

H-Index

Page 1

	Year	Citations
Targeting Tumors with IL-10 Prevents Dendritic Cell-Mediated CD8+ T Cell Apoptosis Jian Qiao, Zhida Liu, Chunbo Dong, Cancer Cell	2019	168
Tumor cells suppress radiation-induced immunity by hijacking caspase 9 signaling Chuanhui Han, Zhida Liu, Yunjia Zhang, Nature Immunology Radiation OncologyCancer ImmunosurveillanceRadiation TherapyRadiation BiologyMedicine	2020	140
Genetically Programmable Fusion Cellular Vesicles for Cancer Immunotherapy Qian‐Fang Meng, Yuyue Zhao, Chunbo Dong, Angewandte Chemie International Edition EngineeringImmunologyExtracellular MicrovesiclesImmunotherapeuticsImmune Cell Therapy	2021	114
Synergistic STING activation by PC7A nanovaccine and ionizing radiation improves cancer immunotherapy Min Luo, Zhida Liu, Xinyi Zhang, Journal of Controlled Release Cancer ImmunosurveillancePc7a NanovaccineImmunologyTherapeutic VaccineTumor Targeting	2019	93
AXL targeting restores PD-1 blockade sensitivity of STK11/LKB1 mutant NSCLC through expansion of TCF1+ CD8 T cells Huiyu Li, Zhida Liu, Longchao Liu, Cell Reports Medicine	2022	88
Targeting tumors with IL-21 reshapes the tumor microenvironment by proliferating PD-1intTim-3–CD8+ T cells Sisi Deng, Zhichen Sun, Jian Qiao, JCI Insight Radiation OncologyPd-1inttim-3–cd8+ T CellsCancer ImmunosurveillanceMedicineImmunology	2020	61
Hypofractionated EGFR tyrosine kinase inhibitor limits tumor relapse through triggering innate and adaptive immunity Zhida Liu, Chuanhui Han, Chunbo Dong, Science Immunology MedicineReceptor Tyrosine KinaseImmunologyTumor ImmunityCancer Growth	2019	40
Poly(ethyl ethylene phosphate): Overcoming the “Polyethylene Glycol Dilemma” for Cancer Immunotherapy and mRNA Vaccination Xinyang Yu, Hongjian Li, Chunbo Dong, ACS Nano	2023	28
Advancements in conventional cancer therapy combined with immunotherapy Hongxia Li, Songyan Han, Chunbo Dong, Oncology and Translational Medicine	2024	21
Coordinating interleukin-2 encoding circRNA with immunomodulatory lipid nanoparticles to potentiate cancer immunotherapy Kai Yang, Bing Bai, Xiaomei Li, Science Advances	2025	15

Page 1